Tagged with industry

Portugal The Portuguese secretary of state for industry invites readers to discover the vibrant tech landscape in Portugal. Ana Teresa Lehmann unravels the reasons why Portugal is such an exciting investment destination and the value of new projects including free tech zones and initiatives to link corporates and startups. Since July…

Poland The value of Poland’s pharmaceutical exports shot from USD 501 million in 2005 to USD 3.475 billion in 2015, a total growth of an astounding 590% and a compound annual growth rate of 21%. Most exports go to Europe (80%) but Asian markets are becoming increasingly important to Poland and…

China The Greater Bay Area (several cities in Guangdong Province in mainland China along with Hong Kong and Macau) is a major Chinese government scheme to link the entire region into an integrated economic and business hub . The Greater Bay Area, taken as a whole, dwarfs the world’s other major…

Pharma India leads the way in terms of the sheer volume of US FDA-approved manufacturing plants with over 100, compared to only 28 in China. In terms of the global competitiveness of Brazil, Russia, India, China and South Africa (BRICS), China remained out in front between 2012 and 2015, with India…

Serbia Serbia macroeconomic factsheet including data on population, GDP, education and life expectancy. Serbia has risen 50 places in the World Bank’s ‘Doing Business’ rankings from 93rd in 2014 to 43rd in 2018. Serbia’s GDP per capita between 2008 and 2016. International comparison of healthcare spending growth and GDP growth between…

Tunisia Tunisia’s GDP percentage change year on year. After suffering a major slump in 2011, the economy is now on the road to recovery.   In terms of ease of doing business, Tunisia lags behind the UAE and Morocco but fares better than Jordan, Egypt and Lebanon. Public spending accounts for…

Ukraine Healthcare expenditure as a share of GDP has shrunk dramatically in Ukraine since 2013. Hospitals bear the brunt of primary care in Ukraine. WHO standards require a far greater role for family doctors within the overall healthcare system. Life expectancy in Ukraine lags behind that of its neighbors and peers.…

Colombia Colombia macroeconomic snapshot. Colombia GDP 1996-2016. GDP growth in South Americabetween 2015 and 2018. Colombia stands out for economic reliability in a region of uncertainty. Per capita healthcare expenditure in Latin America; Colombia stood in 9th place in 2014. Colombia healthcare snapshot. Healthcare expenditure in Colombia up until 2021. Pharma…

Hong Kong Hong Kong’s top 10 trading partners. Mainland China is by far the most significant partner in terms of both imports and exports. Hong Kong at a glance and its important relationship to the massive China market. Healthcare expenditure in Hong Kong as a percentage of GDP compared to other countries.…

Indonesia Indonesia in figures. Indonesia’s population is projected to grow to 305.6 million by 2035. Indonesia’s universal healthcare coverage program (JKN) has grown exponentially in recent years to cover around 172 million people in 2016. Indonesia spends less on healthcare than many of its regional peers, with only Laos and Myanmar…

Algeria Algeria’s key macroeconomic and healthcare indicators. Cardiovascular disease prevalence in North Africa.  Diabetes prevalence in North Africa. The rate of change in the number of years of healthy life lost to obesity in Africa. Click here to download the latest roundtable discussion on Algerian healthcare.

Japan Prof. Yoshiaki Tsukamoto, executive director of the Japan Bioindustry Association (JBA), talked exclusively to PharmaBoardroom at the BIO 2017 conference in San Diego on the role of his organization within Japan and his mission to instill a start-up culture within the Japanese biopharmaceutical industry. “[My mission is] urging universities, biotech start-ups…